Skip to main content
AnorMED Inc. logo

AnorMED Inc. — Investor Relations & Filings

TSX Professional, scientific and technical activities
Filings indexed 0 across all filing types
Latest filing no filings yet
Country CA Canada
Listing TSX

About AnorMED Inc.

www.anormed.com

AnorMED Inc. was a chemistry-based biopharmaceutical company focused on the discovery, research, and development of small molecule therapeutics. The company specialized in applying chemistry, biochemistry, and biology to create novel treatments, primarily targeting serious diseases such as cancer and HIV. A key compound in its portfolio, AMD-3100, reached Phase III clinical development. AnorMED Inc. ceased independent operations in October 2006 following its acquisition by Genzyme Corporation for approximately US$584 million.

Recent filings

No filings indexed yet

We are still gathering filings for AnorMED Inc.. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.